TABLE VI.
General Topics | N | %* |
---|---|---|
Injury | 121 | 39.0 |
Surgical management/approach | 81 | 26.1 |
Epidemiology | 57 | 18.4 |
Surgical outcomes | 35 | 11.3 |
Congenital/metabolic | 33 | 10.6 |
Education and training | 33 | 10.6 |
Deformity/dysplasia | 32 | 10.3 |
Adverse events | 30 | 9.7 |
Predictors/risk factors | 29 | 9.4 |
Reconstruction/replacement | 26 | 8.4 |
Degenerative | 25 | 8.1 |
Health care delivery/administration | 24 | 7.7 |
Infection | 23 | 7.4 |
Validation | 21 | 6.8 |
Consensus/priorities/guidelines | 17 | 5.5 |
COVID-19 | 16 | 5.2 |
Pharmacology | 15 | 4.8 |
Orthopaedic research | 14 | 4.5 |
Basic science | 13 | 4.2 |
Economic analysis | 13 | 4.2 |
Public health/prevention | 13 | 4.2 |
Nonsurgical management/approach | 10 | 3.2 |
Nonsurgical outcomes | 10 | 3.2 |
Orthopaedic partnership review | 9 | 2.9 |
Pain management/anesthesia | 9 | 2.9 |
Genetics | 7 | 2.3 |
Imaging/radiology | 7 | 2.3 |
General orthopaedics | 6 | 1.9 |
Bone healing | 4 | 1.3 |
Traditional medicine | 4 | 1.3 |
Anatomy | 3 | 1.0 |
Rehabilitation | 3 | 1.0 |
Perioperative management | 2 | 0.6 |
Percentage of total articles (n = 310).